Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Mark Baldry | Chief Commercial Officer | 2025-05-16 | 1,032 | $2.48 | $2.56kBuy |
Mark Baldry | Chief Commercial Officer | 2025-05-16 | 1,032 | $2.48 | $2.56kBuy |
Christophe Arbetengels | Chief Medical Officer | 2025-01-24 | 11,624 | $0.46 | $5.29kSell |
Mark Baldry | Chief Commercial Officer | 2025-01-24 | 29,159 | $0.45 | $13.24kSell |
Mary Dibiase | Chief Operating Officer | 2025-01-24 | 22,258 | $0.45 | $10.11kSell |
Adam S. Mostafa | Chief Financial Officer | 2025-01-24 | 74,773 | $0.45 | $33.95kSell |
Paula Ragan | President and CEO | 2025-01-24 | 76,473 | $0.45 | $34.72kSell |
Mark Baldry | Chief Commercial Officer | 2024-11-15 | 13,404 | $0.34 | $4.60kBuy |
Paula Ragan | President and CEO | 2024-11-15 | 31,897 | $0.40 | $12.60kSell |
Paula Ragan | President and CEO | 2024-10-15 | 31,897 | $0.56 | $17.93kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Paula Ragan | 57.65% | 3,337,386 | $12.15M | Insider |
Mary Dibiase | 19.71% | 1,140,980 | $4.15M | Insider |
Christophe Arbetengels | 14.93% | 864,207 | $3.15M | Insider |
Adam S. Mostafa | 14.68% | 850,000 | $3.09M | Insider |
Bain Capital Life Sciences Investors LLC | 9.74% | 563,859 | $2.05M | Institution |
Nea Management Company LLC | 8.63% | 499,559 | $1.82M | Institution |
Arthur Taveras | 6.70% | 388,026 | $1.41M | Insider |
Adam R. Craig | 5.01% | 289,881 | $1.06M | Insider |
John Volpone | 5.01% | 289,881 | $1.06M | Insider |
Kingdon Capital Management LLC | 4.03% | 233,332 | $849.33k | Institution |